Targeted Importation: A Drug Pricing Mechanism For 'Predatory Actors' And An A-Pauling HHS Confirmation Dilemma

For those old drug re-pricing situations that reach headline and/or US congressional visibility, a tweak to the importation debate might offer a response.

Arrows miss target

More from Pricing Debate

More from Market Access